Page 149 - ITPS-7-2
P. 149
INNOSC Theranostics and
Pharmacological Sciences Dapsone enhance skin flap survival
46. Modschiedler K, Weller M, Wörl P, von den Driesch P. Sci. 2018;19(6):744-749.
Dapsone and colchicine inhibit adhesion of neutrophilic doi: 10.4142/jvs.2018.19.6.744
granulocytes to epidermal sections. Arch Dermatol Res.
2000;292(1):32-36. 57. Nezamoleslami S, Sheibani M, Jahanshahi F, Mumtaz F,
Abbasi A, Dehpour AR. Protective effect of dapsone against
doi: 10.1007/pl00007458 renal ischemia-reperfusion injury in rat. Immunopharmacol
47. Suda T, Suzuki Y, Matsui T, et al. Dapsone suppresses Immunotoxicol. 2020;42(3):272-279.
human neutrophil superoxide production and elastase doi: 10.1080/08923973.2020.1755308
release in a calcium-dependent manner. Br J Dermatol.
2005;152(5):887-895. 58. Sheibani M, Nezamoleslami S, Faghir-Ghanesefat H,
Emami AH, Dehpour AR. Cardioprotective effects of
doi: 10.1111/j.1365-2133.2005.06559.x dapsone against doxorubicin-induced cardiotoxicity in rats.
48. Zalewska A, Napieralska-Krzysiek E. [Dapsone in skin Cancer Chemother Pharmacol. 2020;85(3):563-571.
diseases]. Pol Merkur Lekarsk. 2003;15(89):484-486. doi: 10.1007/s00280-019-04019-6
49. Khalilzadeh M, Shayan M, Jourian S, Rahimi M, Sheibani M, 59. Kast RE, Lefranc F, Karpel-Massler G, Halatsch ME. Why
Dehpour AR. A comprehensive insight into the anti- dapsone stops seizures and may stop neutrophils’ delivery of
inflammatory properties of dapsone. Naunyn Schmiedebergs VEGF to glioblastoma. Br J Neurosurg. 2012;26(6):813-817.
Arch Pharmacol. 2022;395(12):1509-1523.
doi: 10.3109/02688697.2012.674577
doi: 10.1007/s00210-022-02297-1
60. Kast RE. Dapsone as treatment adjunct in ARDS. Exp Lung
50. Kuhn A, Ruland V, Bonsmann G. Cutaneous lupus Res. 2020;46(5):157-161.
erythematosus: Update of therapeutic options part II. J Am
Acad Dermatol. 2011;65(6):e195-e213. doi: 10.1080/01902148.2020.1753266
61. Kast RE, Hill QA, Wion D, et al. Glioblastoma-
doi: 10.1016/j.jaad.2010.06.017
synthesized G-CSF and GM-CSF contribute to growth
51. Stannard JN, Kahlenberg JM. Cutaneous lupus and immunosuppression: Potential therapeutic benefit
erythematosus: Updates on pathogenesis and from dapsone, fenofibrate, and ribavirin. Tumour Biol.
associations with systemic lupus. Curr Opin Rheumatol. 2017;39(5):1010428317699797.
2016;28(5):453-459.
doi: 10.1177/1010428317699797
doi: 10.1097/bor.0000000000000308
62. Qian LW, Fourcaudot AB, Yamane K, You T, Chan RK,
52. Kozub P, Simaljakova M. Hidradenitis suppurativa treated Leung KP. Exacerbated and prolonged inflammation impairs
with combination of infliximab and dapsone. Bratisl Lek wound healing and increases scarring. Wound Repair Regen.
Listy. 2012;113(5):319-323. 2016;24(1):26-34.
doi: 10.4149/bll_2012_074 doi: 10.1111/wrr.12381
53. Geyfman M, Debabov D, Poloso N, Alvandi N. Mechanistic 63. Ellis S, Lin EJ, Tartar D. Immunology of wound healing.
insight into the activity of a sulfone compound dapsone on Curr Dermatol Rep. 2018;7(4):350-358.
Propionibacterium (Newly Reclassified as Cutibacterium) doi: 10.1007/s13671-018-0234-9
Acnes-mediated cytokine production. Exp Dermatol.
2019;28(2):190-197. 64. Harder Y, Amon M, Laschke M, et al. An old dream
revitalised: Preconditioning strategies to protect surgical
doi: 10.1111/exd.13869 flaps from critical ischaemia and ischaemia-reperfusion
54. Köstler E, Wollina U. Ulcerated necrobiosis lipoidica: injury. J Plast Reconstr Aesthet Surg. 2008;61(5):503-511.
A combined treatment approach with dermatosurgery and doi: 10.1016/j.bjps.2007.11.032
PUVA. Int J Low Extrem Wounds. 2003;2(4):243-245.
65. Hosnuter M, Babucçu O, Kargi E, Altinyazar C. Dual
doi: 10.1177/1534734603260680 preconditioning: Effects of pharmacological plus ischemic
55. Erfurt-Berge C, Heusinger V, Reinboldt-Jockenhöfer F, preconditioning on skin flap survival. Ann Plast Surg.
Dissemond J, Renner R. Comorbidity and therapeutic 2003;50(4):398-402.
approaches in patients with necrobiosis lipoidica. doi: 10.1097/01.SAP.0000037261.84618.7F
Dermatology. 2022;238:148-155.
66. Gözü A, Poda M, Taskin EI, et al. Pretreatment with
doi: 10.1159/000514687 octreotide modulates iNOS gene expression, mimics
56. Kwon MJ, Joo HG. Dapsone modulates lipopolysaccharide- surgical delay, and improves flap survival. Ann Plast Surg.
activated bone marrow cells by inducing cell death and 2010;65(2):245-249.
down-regulating tumor necrosis factor-α production. J Vet doi: 10.1097/SAP.0b013e3181c1fe8f
Volume 7 Issue 2 (2024) 12 doi: 10.36922/itps.2241

